Evogene Capital Expenditures (CapEx) Growth & History (EVGN)

Evogene's capital expenditures (capex) was $135,000 for fiscal 2025.

View full Evogene company overview

Evogene annual capital expenditures (capex) history

Evogene annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20252025-12-31$135,000−$491,000−78.43%
20242024-12-31$626,000$49,000+8.49%
20232023-12-31$577,000−$594,000−50.73%
20222022-12-31$1.2M$324,000+38.25%
20212021-12-31$847,000$165,000+24.19%
20202020-12-31$682,000−$218,000−24.22%
20192019-12-31$900,000$526,000+140.64%
20182018-12-31$374,000−$216,000−36.61%
20172017-12-31$590,000−$218,000−26.98%
20162016-12-31$808,000−$1.2M−59.70%
20152015-12-31$2.0M

Evogene capital expenditures (capex) trends

Over the last five fiscal years, Evogene's capital expenditures (capex) decreased from $682,000 to $135,000, a change of −$547,000. The latest reported quarter, Q2 2026, shows $9,000.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Evogene source filings ↗

Community posts

It’s quiet here.

No posts about EVGN yet. Start the conversation.

Write the first post